Analysis of differentially expressed genes in neuroendocrine carcinomas of the lung

J Thorac Oncol. 2006 Oct;1(8):780-6.

Abstract

Introduction: Large cell neuroendocrine carcinoma (LCNEC) and small cell lung carcinoma (SCLC) show considerable differences in their histology but share neuroendocrine (NE) characteristics and also genetic and/or expression patterns.

Methods: We used the subtractive expression method to identify differences in gene expression that would allow discrimination between these two types of NE lung carcinoma.

Results: Eight cDNA fragments were transcribed at a higher level in LCNEC compared with SCLC, and these corresponded to five mitochondrial genes, two ribosomal genes, and one fetal regulation factor, neuronatin (NNAT). Immunohistochemically, NNAT protein was detected in 43% (6/14) of LCNECs but in only 8% (1/13) of SCLCs (p < 0.05). Positive staining for NNAT was observed in areas that did not show the NE morphology, such as palisading and rosettes.

Conclusions: The present results suggest that NNAT has the potential to be used as a differential maker between LCNEC and SCLC.

MeSH terms

  • Animals
  • Biomarkers, Tumor / analysis
  • CD56 Antigen / analysis
  • Carcinoma, Large Cell / diagnosis
  • Carcinoma, Large Cell / genetics*
  • Carcinoma, Neuroendocrine / diagnosis
  • Carcinoma, Neuroendocrine / genetics*
  • Carcinoma, Small Cell / diagnosis
  • Carcinoma, Small Cell / genetics*
  • Chromogranin A / analysis
  • Diagnosis, Differential
  • Female
  • Gene Expression Profiling*
  • Humans
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / genetics*
  • Male
  • Membrane Proteins / analysis
  • Mice
  • Mice, SCID
  • Nerve Tissue Proteins / analysis
  • Oligonucleotide Array Sequence Analysis
  • RNA, Messenger / genetics
  • Synaptophysin / analysis

Substances

  • Biomarkers, Tumor
  • CD56 Antigen
  • Chromogranin A
  • Membrane Proteins
  • NNAT protein, human
  • Nerve Tissue Proteins
  • RNA, Messenger
  • Synaptophysin